Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2001-8-15
pubmed:abstractText
After an episode of acute bleeding from esophageal varices, patients are at high risk for recurrent bleeding and death. We compared two treatments to prevent recurrent bleeding--endoscopic ligation and combined medical therapy with nadolol and isosorbide mononitrate.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0028-4793
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
345
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
647-55
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11547718-Actuarial Analysis, pubmed-meshheading:11547718-Adrenergic beta-Antagonists, pubmed-meshheading:11547718-Drug Therapy, Combination, pubmed-meshheading:11547718-Endoscopy, pubmed-meshheading:11547718-Esophageal and Gastric Varices, pubmed-meshheading:11547718-Female, pubmed-meshheading:11547718-Gastrointestinal Hemorrhage, pubmed-meshheading:11547718-Hemodynamics, pubmed-meshheading:11547718-Humans, pubmed-meshheading:11547718-Isosorbide Dinitrate, pubmed-meshheading:11547718-Ligation, pubmed-meshheading:11547718-Male, pubmed-meshheading:11547718-Middle Aged, pubmed-meshheading:11547718-Nadolol, pubmed-meshheading:11547718-Postoperative Complications, pubmed-meshheading:11547718-Recurrence, pubmed-meshheading:11547718-Regression Analysis, pubmed-meshheading:11547718-Survival Analysis, pubmed-meshheading:11547718-Vasodilator Agents
pubmed:year
2001
pubmed:articleTitle
Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
pubmed:affiliation
Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. cvillaneuva@hsp.santpau.es
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't